检索历史 清除

目的 检测胰腺癌组织和胰腺癌细胞株SW1990和PANC1的12-脂氧合酶(12-lipooxygenase,12-LOX)表达,探讨其与胰腺癌临床病理参数的关系.方法 分别应用免疫组化染色、RT-PCR和蛋白质印迹法检测胰腺癌组织、癌旁正常胰腺组织及胰腺癌细胞株SW1990和PANC1中12-LOX mRNA和蛋白的表达.分析胰腺癌组织12-LOX表达与临床病理参数的相关性.结果 30例胰腺癌组织12-LOX表达阴性8例,弱阳性7例,强阳性15例,总阳性率为73.3％.SW1990和PANC1细胞均表达12-LOX.阳性表达的胰腺癌组织及两株胰腺癌细胞株均表达12-LOX mRNA,而癌旁正常胰腺组织不表达12-LOX mRNA及蛋白.胰腺癌组织12-LOX强阳性表达与肿瘤TNM分期、肿瘤病理分级和淋巴结转移相关(P＜0.05),而与患者年龄、性别无关.结论 12-LOX在胰腺癌中表达上调,与胰腺癌的恶性生物学行为有关.

Objectives To study the expression of lipoxygenase-12 (12-LOX) in human pancreatic adenocarcinoma and its relationship with the clinicopathological parameters.Methods Expression of 12-LOX in pancreatic carcinoma tissue,pancreatic cancer cell lines SW1990 and PANC1,and adjacent normal pancreatic tissue was detected by using immunohistochemistry,RT-PCR,and Western blot,respectively.The relationship between 12-LOX expression and clinicopathological parameters was analyzed.Results Expression of 12-LOX was negative in 8 cases,weak positive in 7 cases and strong positive in 15 cases of pancreatic carcinoma.The overall positive rate in pancreatic carcinoma was 73.3％.The expressions of 12-LOX mRNA and protein were positive in pancreatic cancer cell lines SW1990 and PANC1,and negative in adjacent normal pancreatic tissue.The strong positive expression of 12-LOX in pancreatic cancer was associated with TNM stage,pathological grade,lymph node metastasis (P ＜ 0.05 ).Conclusions The expression of 12-LOX was up-regulated in pancreatic cancer and is correlated well to malignant behaviors of tumor.